Abstract: Production of genetically modified crops and animals is still a widely debated topic across the globe. There are a lot of players when it comes to the acceptance and adoption of biotechnology in agriculture for the aim of increased food production, quality addition among other goals. One of the key stake holders are policy makers. Many African countries have developed Agricultural policies which address the research, development, production and regulation of genetically engineered crops and animals. Through these policies, A number of new crops have been developed tested and approved, addressing important traits of particular significance for smallholder farmers in Africa. Since most of these policies are still new, there are issues that face the agricultural biotechnology sector in these countries that making it difficult to achieve the potential. The major problems include misinformation and politicization of core issues relating to biotechnology. However, these issues can be addressed easily with implementation of the guidelines delayed in the policy. Kenya developed and adopted such a comprehensive policy in 2006. However, to date, the full implementation and complete adherence to the document guidelines has not been fully achieved. This paper uses several case studies to review the Agricultural Biotechnology policy in Kenya, evaluating what is outlined in the policy adopted slightly more than a decade ago against what has been achieved so far.
Introduction
Kenya is a country in East Africa with coastline on the Indian Ocean. It encompasses savannah, lakelands, the dramatic Great Rift Valley and mountain highlands. It's also home to wildlife like lions, elephants and rhinos. From Nairobi, the capital, safaris visit the Maasai Mara Reserve, known for its annual wildebeest migrations, and Amboseli National Park, offering views of Tanzania's 5,895m Mt. Kilimanjaro. Agriculture remains the backbone of the Kenyan economy, contributing 25% of GDP. About 80% of Kenya's population work at least part-time in the agricultural sector, including livestock and pastoral activities. Over 75% of agricultural output is from small-scale, rain-fed farming or livestock production. Table 1 and Figure 1 show some basic sociodemographic statistics of Kenya and the climatic zones in the country respectively
Background
Biotechnology is defined as any technological application that uses living organisms, or derivatives thereof to make or modify new products or improve existing ones. In spite of advances in biotechnology having great potential to improve an economy, it is imperative that it be applied systematically, responsibly and in a way, that responds to a country's priority needs. In this regard, the government of The map shows the agricultural climate zones as an indicator of the agricultural capacity of the country and the apparent need to adopt biotechnology to attain adequate food production for domestic consumption and possibly export. Source; Wikipedia Kenya developed a comprehensive national policy to guide research, development and commercialization of modern biotechnology products. The policy, which was approved in September 2006, was the result of several years of work involving all major biotechnology stakeholders nationally, internationally working closely with relevant government departments. This paper is a review of the current policy on Agricultural Biotechnology in Kenya.
The Kenya National Biotechnology Development Policy (2006)
The policy covers all biotechnology applications, including tissue culture and micropropagation, biopesticides and biofertilizers, livestock technology, DNA Marker technology, and genetic engineering. It also covers research, development and use of biotechnology in various key fields such as agriculture, environment, human and animal health and industry. The policy takes cognizance of international instruments, such as the Cartagena Protocol on Biosafety. The objectives of this policy include to:
• Prioritize, promote, and coordinate research in basic and applied bio-sciences, • Promote sustainable industrial development for production of biotechnologically derived products, • Create enabling administrative and legal frameworks for biotechnological development and commercialization of such related products,
• Develop mechanisms for the provision of sustainable funding for biotechnology research and products' development, • Support and facilitate capacity building on all aspects of biotechnology including intellectual property access and protection, biosafety and bioethics, • Support the development and retention of human resources in science, innovation and biotechnology, • Stimulate collaboration among public, private sectors and international agencies in order to advance biotechnology both locally and internationally.
• Promote public understanding of the potential benefits and address stakeholder concerns on modern biotechnology.
Scope of the Policy
The government of Kenya adopted biotechnology for the purpose of improving the quality of human welfare, maximizing productivity in agriculture and industry and protecting the environment, conserving biodiversity and bioprospecting. The biotechnology policy therefore seeks to address:
• Traditional and modern biotechnology;
• Genetically modified organisms that are human food and animal feeds and pharmaceuticals.
The policy targets to cover all biotechnology applications including tissue culture and • Contained Use Regulation, 2011;
• Environmental Release Regulation, 2011;
• Import, Export, and Transit Regulation, 2011;
• Labeling Regulation, 2012; and
• Packaging, Transport, and Identification regulation, 2014
The NBA works together with eight other regulatory agencies that have different roles in regulating Biotechnology products. These regulatory agencies are:
• Department of Public Health, under the Ministry of Health, safeguards consumers' health through food safety and quality control, surveillance, prevention and control of food borne diseases. The Agriculture committee has recommended the establishment of a Food Safety and Control Unit to evaluate food safety of GE foods for human consumption, and to issue import permits for GE foods;
• Kenya Bureau of Standards, (KEBS) under the Ministry of Industrialization and Enterprise Development, develops food standards, quality assurance, and testing;
• National Environment Management Authority (NEMA), under the Ministry of Environment, Water, and Natural Resources, oversees environmental questions and conducts environmental impact assessments. NEMA issues licenses that permit national performance trials (NPTs) on GE crops and plants.
• Pest Control Products Board, (PCPB), under the Ministry of Agriculture, Livestock and Fisheries, regulates pesticide use;
• Kenya Wildlife Service (KWS), under the Ministry of Environment and Natural Resources, handles biodiversity and biotechnology related matters in wildlife and forestry;
• Kenya Industrial Property Institute (KIPI), under the Ministry of Industrialization and Enterprise Development, handles intellectual property issues; and,
• Department of Veterinary Services (DVS).
Figure 2 and figure 3 show the process for approving production of Genetically engineered crops developed in Kenya and the regulatory processes of such crops respectively.
Industry and Trade
The National Biosafety Authority (NBA) is responsible for the approval process of import shipments of GE products. The authoritative legislation, Kenya's Biosafety Act of 2009, stipulates that the approval process should take 90-150 days. Also, the Kenya Plant Health Inspectorate Service (KEPHIS) requires imported GE plant products to have: Figure 2 . The Approval process for production of Genetically engineered crops developed in Kenya, Source; National Biosafety Association of Kenya. The figure shows a breakdown of the process due to be followed before a scientist, biotechnologist, or any other individuals or companies can be approved to produce genetically engineered crops in Kenya for whichever goal. 
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• Reverse the GE foods import ban;
• Commercialize Bt cotton;
• Continue public awareness on modern biotechnology and biosafety; and
• Continue capacity building on biotechnology to manage and strengthen research, development and trade
Case Studies for the implementation of the Policy
To further clarify the state of affairs in regard to research activities and the need for action, the following are some case studies of recent agricultural research and development work in Kenya.
Case Study 1: Cotton
Cotton production in Kenya has declined over the years due to yields being affected by bollworm, necessitating the search for varieties that will be resistant to bollworm. Work on Bt. Cotton began with Bt. cotton seeds with a gene of resistance against the bollworm being imported for trials from South Africa in late May 2004 (Kameri-Mbote 2003 . This was after the plant regulatory authority, the Kenya Plant Health Inspectorate Service (KEPHIS) granted KARI a permit to introduce the seeds. The trials were done at KARI Fiber research station in Mwea Tabere whose biosafety facilities have been inspected and approved by KEPHIS on behalf of the National Biosafety Committee. However, upon the success of the project, the seeds were not commercialized. If these seeds were handed to the farmers, this would have a very significant impact on the Kenyan Cotton industry, and the country's economy by proxy.
Case study 2: Maize
The main thrust of agricultural research on maize in Kenya has traditionally focused on breeding for both higher yields and drought tolerance (Smale -Jay 2003) . Not much attention has been given to breeding for pest and disease tolerance and consequently, small-scale farmers have been affected substantially as they plant improved maize varieties under very poor pest and disease management conditions. They end up not benefiting from the yield potential of such varieties.
Stem borers pose one of the most serious threats to the production of maize in Kenya, with losses estimated to be about 15 % of the harvest. These problems have continued to intensify as most subsistence farmers are poor and cannot afford to buy pesticides to curb the menace posed by the borers.
The Insect Resistant Maize for Africa (IRMA)
The Insect Resistant Maize for Africa project started in 1999 by KALRO working together with the International Maize and Wheat Improvement Centre (CIMMYT) with funding from the Syngenta Foundation for Sustainable Agriculture. The overall objective of the project was to increase maize production and enhance food security through the development and deployment of insect resistant maize that is adapted to various agro-ecological zones in Kenya (IRMA).
In furtherance of the objectives of the project, maize leaves with Bt. toxins were imported into Kenya from Mexico and these underwent trials at various KALRO research stations (KameriMbote 2003) . The project was continued in a green house and controlled environments until seeds which were approved as fit, safe and stable for human consumption were obtained at the end of the project.
By the end of the project in 2014, the project had succeeded in developing maize varieties that can better resist attack by the three major insect pests in Kenya -stem borers, maize weevils, and the larger grain borer (LGB).
Nine maize varieties (both open pollinated and hybrid) with remarkable resistance to stem borers were released. They can control three of the four main stem borers (IRMA). 
IRMA project achievements

Key Policy Recommendations
I. Prioritization and Coordination of Research and Development
The policy recommends establishment of a National Biotechnology Enterprises Programme that will consist of a National Commission on Biotechnology, a National Biotechnology Education Centre and a National Biosafety Authority. Although the NBA has already been established, the establishment of the NCB and NBEC is necessary.
II. Public Education and Awareness Creation
1. Creation of public awareness on biotechnology issues and investment opportunities;
2. Access to information held by public authorities;
3. Public participation in decision making process;
4. Access to judicial and administrative provisions.
III. Public Protection and Support
1. Protecting Intellectual Property Rights (IPR) is a critical aspect of biotechnology innovation, and ensuring effective public and private sector participation in research and product development.
2. The Government recognizes the existing policies and legislation on protection of traditional knowledge and resources.
IV. Infrastructure, Facilities and Equipment
The National Biotechnology Enterprises Programme to put in place mechanisms to create linkages and networks among public research institutes and universities for optimum access and utilization of available resources while supporting initiatives for the establishment of biotechnology parks at R & D institutions as incubators to stimulate the growth of small and medium size businesses with potential to mature into high technology companies.
V. Financial and Business Support
The key recommendations here are;
1. Create incentives to encourage partnerships between public research institutes and the private sector 2. Waiver of taxes on research materials and equipment to encourage further research 3. Encourage specialized technological financing agencies to provide loans to firms or consortia and research institutions.
4. Direct public budgetary allocation to biotechnology research and development.
Conclusion
The policy provides a road map for agricultural biotechnology and should effectively guide the country into a pre-eminent position of a knowledge-based economy for overall sustainable economic growth, poverty alleviation and wealth creation.
The policy is well structured and covers the most key issues dealing with biotechnology in the country. However, its slow implementation and unclear distinction of the parts played by different agencies defined within it may cause conflicts and thus slow down the progress of the country towards having an efficient biotechnology framework. It is crucial for the Government to come up with an evaluation strategy to evaluate the effectiveness and efficiency of the policy so as to find out rising issues as the implementation roles out further. Moreover, the evident interference on the implementation of the policy by the political class should be closely monitored and strictly regulated.
